Activated Clotting Time as a Marker of Inflammation in Hospitalized Patients. Clin Appl Thromb Hemost • June 2, 2020
Analysis of Effectiveness, Safety, and Bleeding Related to Rivaroxaban in Elderly Patients. Clin Appl Thromb Hemost • May 27, 2020
Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study. Clin Appl Thromb Hemost • November 21, 2019
Patient Satisfaction With Venous Thromboembolism Treatment. Clin Appl Thromb Hemost • August 14, 2019
Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? Clin Appl Thromb Hemost • June 27, 2019
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium. Clin Appl Thromb Hemost • June 13, 2019
Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism. Clin Appl Thromb Hemost • May 28, 2019
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review. Clin Appl Thromb Hemost • May 16, 2019
The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study. Clin Appl Thromb Hemost • March 29, 2019
Comparison of Venous Thrombosis Complications in Midlines Versus Peripherally Inserted Central Catheters: Are Midlines the Safer Option? Clin Appl Thromb Hemost • March 27, 2019